CMS has increased the oversight of antipsychotic medications and associated diagnoses. Without further action, skilled nursing facilities could be at risk for significant penalties. This session will teach participants how to avoid penalties and ensure appropriate documentation is in place for residents receiving antipsychotic medications.

LEARNING OBJECTIVES

1. Understand QSO-23-05-NH and its implications in skilled nursing facilities.
2. Identify medications associated with the antipsychotic drug class and appropriate diagnoses for their use in the long-term care setting.
3. Explain the documentation and services needed to support residents receiving antipsychotic medications in long-term care.
4. Implement strategies to protect your facility from penalties associated with inaccurate schizophrenia diagnosis and coding.
5. Discover best practices for assisted living facilities surrounding the use of antipsychotic medications.

PRESENTERS

Brianne Gerron, RN, BSN and Rebecca Ortmeier, PharmD

CONTINUING EDUCATION

1 hour of continuing education from Nebraska DHHS Regulation and Licensure, Board of NHA has been approved for this webinar. Appropriate records will be maintained for other disciplines to receive credit from their credentialing organizations. Nursing contact hours are NOT available for this webinar. If you are registering for someone else, please make sure to email Natalie McCormick at [email protected] the person(s) name and address. Class material and the zoom link will be sent 2 days prior to the class.

REGISTRATION FEES

LeadingAge Nebraska members: $25
Non-members: $50

CANCELLATION POLICY

No refunds will be given for cancellations for this webinar, but substitutions are welcome. No shows will be billed. Please email Natalie McCormick at [email protected] with the new name and email address.

REGISTER